Advances in Peritoneal Surface Oncology by Paul H. Sugarbaker MD, FACS, FRCS (auth.), Santiago

By Paul H. Sugarbaker MD, FACS, FRCS (auth.), Santiago González-Moreno MD, PhD (eds.)

S. González-Moreno (Ed. ) Advances in Peritoneal floor Oncology With forty five Figures in fifty seven Separate Illustrations, 12 in colour and 19 Tables 123 IV Preface Santiago González-Moreno, MD, PhD division of Surgical Oncology Centro Oncológico MD Anderson foreign España Calle Gómez Hemans 2 28033 Madrid Spain sgonzalez@mdanderson. es Library of Congress keep an eye on quantity: 2006937141 ISSN 0080-0015 ISBN 978-3-540-30759-4 Springer Berlin Heidelberg ny This paintings is topic to copyright. All rights are reserved, even if the full or a part of the cloth is anxious, speci? ?cally the rights of translation, reprinting, reuse of illustrations, recitations, broadcasting, replica on micro? ?lm or in the other means, and garage in information banks. Duplication of this ebook or elements thereof is authorized simply less than the provisions of the German Copyright legislations of September nine, 1965, in its present model, and permission to be used should always be received from Springer-Verlag. Violations are chargeable for prosecution below the German Copyright legislations. Springer is a part of Springer Science+Business Media http//www. springer. com Springer-Verlag Berlin Heidelberg 2007 published in Germany using common descriptive names, emblems, and so on. during this book doesn't mean, even within the absence of a speci? ?c sta- ment, that such names are exempt from the appropriate protecting legislation and rules and hence unfastened for normal use. Product legal responsibility: The publishers can't warrantly the accuracy of any information regarding dosage and alertness contained during this e-book. In each case the person needs to money such details via consulting the appropriate literature.

Show description

Read or Download Advances in Peritoneal Surface Oncology PDF

Best oncology books

Endocrine Therapy in Breast Cancer

This reference evaluates and describes the newest options for hormone suppression and blockade within the administration of early and complicated degree breast melanoma and explores the results of tamoxifen, selective estrogen receptor modulators (SERMs), aromatase inhibitors, and their blend on either breast cancers and basic tissues.

Molecular Basis for Therapy of AIDS-Defining Cancers

An elevated possibility for varied cancers is a attribute of individuals dwelling with HIV an infection. even if merely 3 cancers – Kaposi’s sarcoma, high-grade B-cell lymphomas, and invasive cervical melanoma – are thought of to be "AIDS-defining" stipulations, are linked to oncogenic viruses, and ensue with elevated frequency as immune functionality declines, different melanoma varieties additionally happen considerably extra usually in HIV-positive members than within the basic inhabitants, yet aren't at once linked to medical development to AIDS.

Comparative Effectiveness in Surgical Oncology: Key Questions and How to Answer Them

Regardless of great fresh advances within the remedy of so much malignancies, there stay a number of severe questions for every melanoma. This quite real for the surgical administration of solid-organ malignancies. Comparative effectiveness is a comparatively new time period which encompasses the age-old recommendations of ways top to regard melanoma sufferers.

Cancer Gene Profiling: Methods and Protocols

This moment variation quantity brings jointly the reviews of major scientists within the self-discipline of melanoma gene profiling. simply because melanoma genes should be profiled in lots of alternative ways, melanoma Gene Profiling: tools and Protocols, moment variation explores various innovations and ways had to comprehend the main phases of melanoma improvement, as utilizing just one strategy will be inadequate.

Additional resources for Advances in Peritoneal Surface Oncology

Sample text

In this regard, ACPS data are also supportive of this, with a very recent study showing LPI to be predictive of locoregional occurrence and an independent influence on overall survival [57]. 6 Summary and Conclusions A large proportion of the luminal GI tract is covered by serosa and we increasingly recognise the importance of involvement of the serosal surface and its influence on locoregional recurrence and survival in most of the main cancers that occur in the GI tract. Thus there is an ever-burgeoning responsibility upon diagnostic histopathologists to introduce appropriate methodology to accurately identify this parameter in GI cancer resection specimens.

Yonemura Y, Eno Y, Tabata K et al. (2005) Role of VEGF-C and VEGF-D on lymphangiogenesis in gastric cancer. Int J Clin Oncol 10:318–327 18. Shimotsuma M, Simpson-Morgan MW, Takahashi T et al. (1992) Activation of omental milky spots and milky spot macrophages by intraperitoneal administration of a streptococcal preparation, OK-432. Cancer Res 52:5400–5402 19. Esperanca MJ, Collins D (1966) Peritoneal dialysis efficiency in relation to body weight. J Ped Surg 1:162–169 20. Inoue H, Matsuyama A, Mimori K et al.

This may be useful for the classification of patients for suitable therapeutic trials. 3 Clinical Implications and Significance fi of a Positive Cytology The prognosis of patients with potentially curable gastric cancer and intraperitoneal free cancer cells (P0Cy1) is very poor, because almost all patients with P0Cy1 status die 3 years after gastrectomy because of peritoneal recurrence. Simple gastrectomy without additional lymphadenectomy is the optimal strategy for the treatment [30]. Chemotherapy regimens like intravenous 5-fluorouracil (5-FU) infusion [40] alone or in combination with other anticancer drugs (FAM [41], FAMTX [42]) have been used for these patients.

Download PDF sample

Rated 4.01 of 5 – based on 26 votes